Table:
begin	end	state
1	26	cytoplasmic
27	47	transmembrane
48	53	non-cytoplasmic
54	73	transmembrane
74	106	cytoplasmic
107	129	transmembrane
130	134	non-cytoplasmic
135	153	transmembrane
154	163	cytoplasmic
164	187	transmembrane
188	207	non-cytoplasmic
208	230	transmembrane
231	249	cytoplasmic
250	270	transmembrane
271	290	non-cytoplasmic
291	313	transmembrane
314	343	cytoplasmic
344	361	transmembrane
362	366	non-cytoplasmic
367	388	transmembrane
389	408	cytoplasmic
409	431	transmembrane
432	436	non-cytoplasmic
437	456	transmembrane
457	472	cytoplasmic

Input:
>AO353_16120
MTVGNHLPHGETAQGGPLKRELGERHIRLMALGACIGVGLFLGSAKAIEMAGPAIMLSYI
IGGLAILVIMRALGEMAVHNPVAGSFSRYAQDYLGPLAGFLTGWNYWFLWLVTCVAEITA
VAVYMGIWFPEVPRWIWALAALVSMGSINLIAVKAFGEFEFWFALIKIVTIIAMVVGGVG
VIAFGFGNDGVALGISNLWSHGGFMPNGVQGVLMSLQMVMFAYLGVEMIGLTAGEAKNPQ
KTIPNAIGSVFWRILLFYVGALFVILSIYPWNEIGTQGSPFVMTFERLGIKTAAGIINFV
VITAALSSCNGGIFSTGRMLYSLAQNGQAPAGFAKTSNGVPRRALLLSIGALLLGVLLNY
LVPEKVFVWVTAIATFGAIWTWVMILLAQLKFRKGLSPAERAALKYRMWLYPVSSYLALA
FLVMVVGLMAYFPDTRVALYVGPAFLVLLTVLFYVFKLQPTGVPQAAVRTAS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server